Synapse - Works

Results (2683)

A six-panel PCR of both plasma and blood for EBV-DNA as tumor marker for nasopharyngeal carcinoma patients treated in the United States

Meeting Abstract

Weiss, J.; Xavier, M.; Tsai, D.; Arnoldi, S.; Sherman, E.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase III trial of gemcitabine plus docetaxel (GD) compared to capecitabine plus docetaxel (CD) with planned crossover to the alternate single agent in metastatic breast cancer (MBC)

Meeting Abstract

Seidman, A. D.; Brufsky, A.; Ansari, R. H.; Rubinsak, J. R.; Stein, R. S.; Schwartzberg, L. S.; Stewart, J. F.; Zhao, L.; Gill, J.; Tai, D.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase IIb/III double-blind randomized trial of BIBW 2992, an irreversible, dual inhibitor of EGFR and HER2 plus best supportive care (BSC) versus placebo plus BSC in patients with NSCLC failing 1-2 lines of chemotherapy (CT) and erlotinib or gefitinib (LUX-Lung1): A preliminary report

Meeting Abstract

Yang, C.; Hirsh, V.; Cadranel, J.; Chen, Y.; Park, K.; Kim, S.; Chao, T.; Oberdick, M.; Shahidi, M.; Miller, V.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Cytokine changes in castrate metastatic prostate cancer (CPMC) patients (pts) treated with ipilimumab (Ipi)

Meeting Abstract

Yuan, J.; Orlandi, F.; Jefferson, M.; Li, H.; Gallardo, H.; Ku, G.; Wolchok, J.; Scher, H.; Allison, J.; Slovin, S. F.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Efficacy of ipilimumab 10 mg/kg in advanced melanoma patients (pts) with good and poor prognostic factors

Meeting Abstract

Wolchok, J. D.; de Pril, V.; Linette, G.; Waterfield, W.; Gajewski, T.; Chiarion-Sileni, V.; Ibrahim, R.; Chin, K.; Hoos, A.; Hamid, O.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Intraperitoneal chemotherapy (IPC) in older women with epithelial ovarian cancer (EOC)

Meeting Abstract

Tew, W. P.; O'Cearbhaill, R.; Zhou, Q.; Thaler, H.; Konner, J.; Hensley, M. L.; Sabbatini, P.; Spriggs, D.; Aghajanian, C.; Lichtman, S. M.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Initial phase II experience of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Slovin, S. F.; Beer, T. M.; Higano, C. S.; Tejwani, S.; Hamid, O.; Picus, J.; Harzstark, A.; Scher, H. I.; Lan, Z.; Lowy, I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Characteristics of young women enrolled in a high-risk breast cancer screening program

Meeting Abstract

Tierney, S.; Delli Carpini, J. C.; Gemignani, M. L.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab

Meeting Abstract

Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Prostate Cancer Clinical Trials Consortium: A multicenter mechanism for the rapid design, development, and implementation of early phase clinical trials

Meeting Abstract

Vinson, J.; Mathew, P.; Beer, T. M.; Carducci, M. A.; Oh, W.; Small, E.; Wilding, G.; Higano, C.; Hussain, M.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save